Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,093 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Screening for diabetes.
Backholer K, Chen L, Shaw J. Backholer K, et al. Among authors: shaw j. Pathology. 2012 Feb;44(2):110-4. doi: 10.1097/PAT.0b013e32834e8e12. Pathology. 2012. PMID: 22228253 Review.
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).
Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group. Marre M, et al. Among authors: shaw j. Diabet Med. 2009 Mar;26(3):268-78. doi: 10.1111/j.1464-5491.2009.02666.x. Diabet Med. 2009. PMID: 19317822 Free PMC article. Clinical Trial.
Risk prediction models for the development of diabetes in Mauritian Indians.
Gao WG, Qiao Q, Pitkäniemi J, Wild S, Magliano D, Shaw J, Söderberg S, Zimmet P, Chitson P, Knowlessur S, Alberti G, Tuomilehto J. Gao WG, et al. Among authors: shaw j. Diabet Med. 2009 Oct;26(10):996-1002. doi: 10.1111/j.1464-5491.2009.02810.x. Diabet Med. 2009. PMID: 19900231
5,093 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page